Search results
Results From The WOW.Com Content Network
In December 2016, Zydus Discovery DMCC, a research subsidiary Zydus Lifesciences, was cited by the US FDA for deliberately misbranding their flagship product, Saroglitazar—the drug used to treat diabetic dyslipidemia in India. In a 21 December 2016 letter to the company, the US FDA asked it to stop using broad statements, such as the "world's ...
Zydus Wellness (previously Carnation Nutra-Analogue Foods) is an Indian consumer goods company headquartered in Ahmedabad, which produces nutrition and skincare products. It is a subsidiary of the pharmaceutical company Zydus Lifesciences (formerly known as Cadila Healthcare).
India's Zydus Lifesciences is aiming to launch its first new drug in the United States by early 2026, looking to tap into the multi-billion dollar market for treating a type of liver disease ...
The products are based upon the company's molecular modeling software for optimizing protein structure. [ 1 ] [ 2 ] [ 3 ] In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. [ 4 ]
Researchers tested 160 products from 70 top protein powder brands, which represented 83 percent of the market, the report says. For the study, an independent certified laboratory ran nearly 36,000 ...
Zydus Lifesciences and Sun Pharmaceuticals have entered an agreement in October 2023 to co-market Desidustat. Sun Pharma will sell the drug as Rytstat , while Zydus will continue to sell it as Oxemia .
The 26-year-old, whose real name is Litzy Lara Banuelos, entered the rehab center for her addiction to the dissociative anesthetic drug, which she was taking 5 to 6 grams of per day, her family ...
This is the talk page for discussing improvements to the Zydus Lifesciences article. This is not a forum for general discussion of the article's subject. Put new text under old text.